Squamous Non-Small Cell Lung Cancer Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Squamous Non-Small Cell Lung Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Overall Market Size
2.1 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size: 2022 VS 2035
2.2 Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Squamous Non-Small Cell Lung Cancer Therapeutics Players in Global Market
3.2 Top Global Squamous Non-Small Cell Lung Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Squamous Non-Small Cell Lung Cancer Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Squamous Non-Small Cell Lung Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Squamous Non-Small Cell Lung Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Squamous Non-Small Cell Lung Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Squamous Non-Small Cell Lung Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size Markets, 2022 & 2035
4.1.2 BMS-906024
4.1.3 Buparlisib Hydrochloride
4.1.4 FP-1039
4.1.5 Ipilimumab
4.1.6 JNJ-42756493
4.1.7 Lenvatinib
4.1.8 Others
4.2 By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2024-2035
4.2.3 By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2022 & 2035
5.1.2 Research Center
5.1.3 Hospital
5.1.4 Clinic
5.2 By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2024-2035
5.2.3 By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2022 & 2035
6.2 By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2024-2035
6.2.3 By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2018-2035
6.3.2 US Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.3.3 Canada Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.3.4 Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2018-2035
6.4.2 Germany Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.4.3 France Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.4.4 U.K. Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.4.5 Italy Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.4.6 Russia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.4.7 Nordic Countries Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.4.8 Benelux Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2018-2035
6.5.2 China Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.5.3 Japan Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.5.4 South Korea Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.5.5 Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.5.6 India Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2018-2035
6.6.2 Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.6.3 Argentina Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2018-2035
6.7.2 Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.7.3 Israel Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.7.4 Saudi Arabia Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
6.7.5 UAE Squamous Non-Small Cell Lung Cancer Therapeutics Market Size, 2018-2035
7 Squamous Non-Small Cell Lung Cancer Therapeutics Companies Profiles
7.1 Ascenta Therapeutics, Inc.
7.1.1 Ascenta Therapeutics, Inc. Company Summary
7.1.2 Ascenta Therapeutics, Inc. Business Overview
7.1.3 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.1.4 Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Ascenta Therapeutics, Inc. Key News & Latest Developments
7.2 AstraZeneca Plc
7.2.1 AstraZeneca Plc Company Summary
7.2.2 AstraZeneca Plc Business Overview
7.2.3 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.2.4 AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.2.5 AstraZeneca Plc Key News & Latest Developments
7.3 AVEO Pharmaceuticals, Inc.
7.3.1 AVEO Pharmaceuticals, Inc. Company Summary
7.3.2 AVEO Pharmaceuticals, Inc. Business Overview
7.3.3 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.3.4 AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.3.5 AVEO Pharmaceuticals, Inc. Key News & Latest Developments
7.4 Bayer AG
7.4.1 Bayer AG Company Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.4.4 Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Bayer AG Key News & Latest Developments
7.5 BIND Therapeutics, Inc.
7.5.1 BIND Therapeutics, Inc. Company Summary
7.5.2 BIND Therapeutics, Inc. Business Overview
7.5.3 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.5.4 BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.5.5 BIND Therapeutics, Inc. Key News & Latest Developments
7.6 Boehringer Ingelheim GmbH
7.6.1 Boehringer Ingelheim GmbH Company Summary
7.6.2 Boehringer Ingelheim GmbH Business Overview
7.6.3 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.6.4 Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.7 Bristol-Myers Squibb Company
7.7.1 Bristol-Myers Squibb Company Company Summary
7.7.2 Bristol-Myers Squibb Company Business Overview
7.7.3 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.7.4 Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Company Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.8.4 Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Eli Lilly and Company Key News & Latest Developments
7.9 F. Hoffmann-La Roche Ltd.
7.9.1 F. Hoffmann-La Roche Ltd. Company Summary
7.9.2 F. Hoffmann-La Roche Ltd. Business Overview
7.9.3 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.9.4 F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.9.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.10 Five Prime Therapeutics, Inc.
7.10.1 Five Prime Therapeutics, Inc. Company Summary
7.10.2 Five Prime Therapeutics, Inc. Business Overview
7.10.3 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.10.4 Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Five Prime Therapeutics, Inc. Key News & Latest Developments
7.11 Genentech, Inc.
7.11.1 Genentech, Inc. Company Summary
7.11.2 Genentech, Inc. Business Overview
7.11.3 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.11.4 Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.11.5 Genentech, Inc. Key News & Latest Developments
7.12 Incyte Corporation
7.12.1 Incyte Corporation Company Summary
7.12.2 Incyte Corporation Business Overview
7.12.3 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.12.4 Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.12.5 Incyte Corporation Key News & Latest Developments
7.13 Johnson & Johnson
7.13.1 Johnson & Johnson Company Summary
7.13.2 Johnson & Johnson Business Overview
7.13.3 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.13.4 Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.13.5 Johnson & Johnson Key News & Latest Developments
7.14 MacroGenics, Inc.
7.14.1 MacroGenics, Inc. Company Summary
7.14.2 MacroGenics, Inc. Business Overview
7.14.3 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.14.4 MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.14.5 MacroGenics, Inc. Key News & Latest Developments
7.15 Novartis AG
7.15.1 Novartis AG Company Summary
7.15.2 Novartis AG Business Overview
7.15.3 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.15.4 Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.15.5 Novartis AG Key News & Latest Developments
7.16 Oncogenex Pharmaceuticals, Inc.
7.16.1 Oncogenex Pharmaceuticals, Inc. Company Summary
7.16.2 Oncogenex Pharmaceuticals, Inc. Business Overview
7.16.3 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.16.4 Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.16.5 Oncogenex Pharmaceuticals, Inc. Key News & Latest Developments
7.17 PsiOxus Therapeutics Limited
7.17.1 PsiOxus Therapeutics Limited Company Summary
7.17.2 PsiOxus Therapeutics Limited Business Overview
7.17.3 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Major Product Offerings
7.17.4 PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global Market (2018-2023)
7.17.5 PsiOxus Therapeutics Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Squamous Non-Small Cell Lung Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Squamous Non-Small Cell Lung Cancer Therapeutics Market Drivers in Global Market
Table 3. Squamous Non-Small Cell Lung Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Squamous Non-Small Cell Lung Cancer Therapeutics in Global Market
Table 5. Top Squamous Non-Small Cell Lung Cancer Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Squamous Non-Small Cell Lung Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Squamous Non-Small Cell Lung Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Squamous Non-Small Cell Lung Cancer Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2024-2035
Table 30. Ascenta Therapeutics, Inc. Company Summary
Table 31. Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 32. Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Ascenta Therapeutics, Inc. Key News & Latest Developments
Table 34. AstraZeneca Plc Company Summary
Table 35. AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 36. AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. AstraZeneca Plc Key News & Latest Developments
Table 38. AVEO Pharmaceuticals, Inc. Company Summary
Table 39. AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 40. AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. AVEO Pharmaceuticals, Inc. Key News & Latest Developments
Table 42. Bayer AG Company Summary
Table 43. Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 44. Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer AG Key News & Latest Developments
Table 46. BIND Therapeutics, Inc. Company Summary
Table 47. BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 48. BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. BIND Therapeutics, Inc. Key News & Latest Developments
Table 50. Boehringer Ingelheim GmbH Company Summary
Table 51. Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 52. Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Company Summary
Table 55. Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 56. Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Bristol-Myers Squibb Company Key News & Latest Developments
Table 58. Eli Lilly and Company Company Summary
Table 59. Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 60. Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Eli Lilly and Company Key News & Latest Developments
Table 62. F. Hoffmann-La Roche Ltd. Company Summary
Table 63. F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 64. F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 66. Five Prime Therapeutics, Inc. Company Summary
Table 67. Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 68. Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Five Prime Therapeutics, Inc. Key News & Latest Developments
Table 70. Genentech, Inc. Company Summary
Table 71. Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 72. Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 73. Genentech, Inc. Key News & Latest Developments
Table 74. Incyte Corporation Company Summary
Table 75. Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 76. Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 77. Incyte Corporation Key News & Latest Developments
Table 78. Johnson & Johnson Company Summary
Table 79. Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 80. Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 81. Johnson & Johnson Key News & Latest Developments
Table 82. MacroGenics, Inc. Company Summary
Table 83. MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 84. MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 85. MacroGenics, Inc. Key News & Latest Developments
Table 86. Novartis AG Company Summary
Table 87. Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 88. Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 89. Novartis AG Key News & Latest Developments
Table 90. Oncogenex Pharmaceuticals, Inc. Company Summary
Table 91. Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 92. Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 93. Oncogenex Pharmaceuticals, Inc. Key News & Latest Developments
Table 94. PsiOxus Therapeutics Limited Company Summary
Table 95. PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Product Offerings
Table 96. PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 97. PsiOxus Therapeutics Limited Key News & Latest Developments
List of Figures
Figure 1. Squamous Non-Small Cell Lung Cancer Therapeutics Segment by Type in 2022
Figure 2. Squamous Non-Small Cell Lung Cancer Therapeutics Segment by Application in 2022
Figure 3. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Squamous Non-Small Cell Lung Cancer Therapeutics Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Squamous Non-Small Cell Lung Cancer Therapeutics Revenue in 2022
Figure 8. By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
Figure 9. By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
Figure 10. By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
Figure 12. By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
Figure 14. By Region - Global Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
Figure 15. By Country - North America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
Figure 16. US Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
Figure 20. Germany Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 21. France Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
Figure 28. China Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 32. India Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
Figure 34. Brazil Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Market Share, 2018-2035
Figure 37. Turkey Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Squamous Non-Small Cell Lung Cancer Therapeutics Revenue, (US$, Mn), 2018-2035
Figure 41. Ascenta Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AstraZeneca Plc Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AVEO Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. BIND Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Boehringer Ingelheim GmbH Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bristol-Myers Squibb Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Eli Lilly and Company Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. F. Hoffmann-La Roche Ltd. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Five Prime Therapeutics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Genentech, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Incyte Corporation Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Johnson & Johnson Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. MacroGenics, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Novartis AG Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Oncogenex Pharmaceuticals, Inc. Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. PsiOxus Therapeutics Limited Squamous Non-Small Cell Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
